An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.
Some experts said the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, marketing, and customer regulations, risking fines, legal action or imprisonment.
Platform Response and Material Removal
Based on TikTok, the service has removed violative material and prohibited related keywords and query recommendations. The organization stated it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Investigations also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, populated with images of weight loss, glowing reviews and detailed guides for mixing or administering at home.
After minutes of joining one group, a seller posted contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, health issues or previous experience.
Product Details and Pricing
Inside these groups, posts display black plastic parcels with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how long a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram stated it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they can’t verify. Although the research behind retatrutide is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to possibly serious health risks”.
